NasdaqGM:TMDXMedical Equipment
TransMedics Group (TMDX) Stock Still Looks Reasonable On Earnings Growth
TransMedics Group stock has more than doubled over the past five years, yet the broader valuation checks still lean cheap, which puts fresh attention on whether the recent pullback has gone too far or not far enough.
Over the past five years, TransMedics Group has returned about 150.4% which keeps the long term story attractive even after a weaker recent stretch.
Future execution on transplant system adoption can support higher earnings power. However, any slowdown in procedure volumes or...